BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 35664009)

  • 41. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
    Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
    Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
    Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy.
    Li X; Wan Z; Liu X; Ou K; Yang L
    Med Oncol; 2022 Jan; 39(4):43. PubMed ID: 35092511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma.
    Feng H; Yang F; Qiao L; Zhou K; Wang J; Zhang J; Tian T; Du Y; Shangguan H
    Front Oncol; 2021; 11():693234. PubMed ID: 34381716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer.
    Yu JS; Huang WB; Zhang YH; Chen J; Li J; Fu HF; Wei ZW; He YL
    Neoplasma; 2022 Jul; 69(4):886-898. PubMed ID: 35603954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers.
    Yu A; Cao M; Zhang K; Yang Y; Ma L; Zhang X; Zhao Y; Ma X; Fan Z; Han Z; Wang H
    Front Immunol; 2023; 14():1256355. PubMed ID: 37868990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma.
    Li R; Huang X; Yang W; Wang J; Liang Y; Zhang T; Mao Q; Xia W; Xu L; Xu X; Dong G; Jiang F
    J Pathol Clin Res; 2022 Sep; 8(5):422-435. PubMed ID: 35711130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer.
    Tokunaga R; Nakagawa S; Sakamoto Y; Nakamura K; Naseem M; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H; Lenz HJ
    Int J Cancer; 2020 Jul; 147(2):532-541. PubMed ID: 32191346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
    Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L
    Front Immunol; 2023; 14():1334408. PubMed ID: 38259481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
    Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
    J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma.
    Xing A; Lv D; Wu C; Zhou K; Zhao T; Zhao L; Wang H; Feng H
    Curr Genomics; 2024 Apr; 25(2):88-104. PubMed ID: 38751598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Tertiary Lymphoid Structures on Prognosis of Patients with Hepatocellular Carcinoma and Preliminary Exploration of Its Formation Mechanism.
    Li J; Nie Y; Jia W; Wu W; Song W; Li Y
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.
    Xu W; Ma C; Liu W; Anwaier A; Tian X; Shi G; Qu Y; Wei S; Zhang H; Ye D
    Cancer Immunol Immunother; 2022 Aug; 71(8):1923-1935. PubMed ID: 35043231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer.
    Mei SQ; Liu JQ; Huang ZJ; Luo WC; Peng YL; Chen ZH; Deng Y; Xu CR; Zhou Q
    Thorac Cancer; 2024 May; 15(14):1119-1131. PubMed ID: 38558529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
    Li YY; Li SJ; Liu MC; Chen Z; Li L; Shen F; Liu QZ; Xu B; Lian ZX
    J Endocrinol Invest; 2023 Nov; 46(11):2247-2256. PubMed ID: 37004696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.
    Lee HJ; Park IA; Song IH; Shin SJ; Kim JY; Yu JH; Gong G
    J Clin Pathol; 2016 May; 69(5):422-30. PubMed ID: 26475777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
    Chen J; Chen J; Wang L
    J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
    Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
    Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tertiary lymphoid structures and gastric cancer prognosis.
    Kemi N; Ylitalo O; Väyrynen JP; Helminen O; Junttila A; Mrena J; Böhm J; Kauppila JH
    APMIS; 2023 Jan; 131(1):19-25. PubMed ID: 36205614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.